Gen-Wealth Partners’s Boston Scientific BSX Stock Holding History

Gen-Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Sell	2,481 -922	-27%	-$50.1K	0.03%	325
2026 Q1	$214K	Sell	3,403 -2,116	-38%	-$169K	0.07%	243
2025 Q4	$526K	Sell	5,519 -4,712	-46%	-$462K	0.17%	126
2025 Q3	$999K	Buy	10,231 +8,326	+437%	+$862K	0.34%	68
2025 Q2	$205K	Buy	1,905 +1,095	+135%	+$111K	0.08%	218
2025 Q1	$81.7K	Hold	810	–	–	0.03%	295
2024 Q4	$72.3K	Buy	+810	New	+$71.3K	0.03%	330
2024 Q3	–	Sell	-1,055	Closed	-$81.2K	–	667
2024 Q2	$81.2K	Buy	+1,055	New	+$77.2K	0.04%	312

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Gen-Wealth Partners's BSX Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Boston Scientific (BSX) stake by 27% in Q2 2026, selling an estimated $50.1K and leaving 2,481 shares worth $106K. The position accounts for 0.03% of the portfolio, ranked #325.

Gen-Wealth Partners first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $999K in Q3 2025. 814 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Gen-Wealth Partners held 2,481 shares of Boston Scientific worth $106K as of Q2 2026.
Gen-Wealth Partners sold 922 Boston Scientific shares in Q2 2026, an estimated $50.1K.
Boston Scientific made up 0.03% of Gen-Wealth Partners's portfolio in Q2 2026, its #325 holding.
Gen-Wealth Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
Gen-Wealth Partners's Boston Scientific position peaked at $999K in Q3 2025.
814 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.